FindTrial
Sign In

Thish study will Compare the Efficacy of spinal anesthesia by Intrathecal Bupivacaine 0.5% versus Intrathecal 0.75% Ropivacaine in patients undergoing Lower Abdominal and Lower Limb Surgeries

A Prospective Randomised Study to Compare the Efficacy of Intrathecal Bupivacaine 0.5% and Intrathecal 0.75% Ropivacaine in Lower Abdominal and Lower Limb Surgeries

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045414
Enrollment
90
Registered
2022-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine 0.75%: Spinal anesthesia (3.2 ml of 7.5mg/ml) Control Intervention1: Bupivacaine 0.5%: Spinal anesthesia (3.2 ml of 5.0 mg/ml)

Sponsors

Dr Rochana Bakhshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing lower limb and lower abdominal surgeries 2. ASA I & II

Exclusion criteria

Exclusion criteria: 1. ASA III & IV 2. Patients not consenting for spinal anesthesia 3. Spine abnormalities in the patient 4. Coagulation disorders 5. Patients with recent history of raised intracranial pressure

Design outcomes

Primary

MeasureTime frame
Onset and duration of motor and sensory blockTimepoint: Immediate (Every two minutes for 20 minutes after administration)—

Secondary

MeasureTime frame
Adverse eventsTimepoint: From time of administration till wearing off of spinal anesthesia;Hemodynamic parameters (SBP, DBP, MAP, HR)Timepoint: Immediate (Every two minutes for 20 minutes after administration)—

Countries

India

Contacts

Public ContactRochana Bakhshi

D Y Patil Medical College Hospital and Research Centre

drrochana@yahoo.com9323272151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026